Comments on Medicare Drug Price Negotiation Program’s Section 30.2 and Part B high spend drugs Pharmaceutical & Drug Policy Comments on Medicare Drug Price Negotiation Program’s Section 30.2 and Part B high spend drugs Samuel R. Bagenstos, Richard G. Frank, Kristi Martin, Rachel Sachs, Christen Linke Young July 14, 2025
International reference pricing for prescription drugs Pharmaceutical & Drug Policy International reference pricing for prescription drugs Christen Linke Young, Richard G. Frank, Rachel Sachs July 9, 2025
Comments on Medicare Drug Price Negotiation Program Pharmaceutical & Drug Policy Comments on Medicare Drug Price Negotiation Program Richard G. Frank, Rachel Sachs, Christen Linke Young July 2, 2025
Recent trends in medication treatment for attention-deficit hyperactivity disorder Pharmaceutical & Drug Policy Recent trends in medication treatment for attention-deficit hyperactivity disorder Haiden A. Huskamp, Alisa Busch, Richard G. Frank June 5, 2025